Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126550172 | 12655017 | 2 | F | 20160808 | 20160808 | 20160816 | 20160928 | EXP | US-ASTRAZENECA-2016SE73651 | ASTRAZENECA | 22795.00 | DY | M | Y | 0.00000 | 20160929 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126550172 | 12655017 | 1 | PS | IRESSA | GEFITINIB | 1 | Oral | 10500 | MG | D | 206995 | 250 | MG | TABLET | QD | ||||
| 126550172 | 12655017 | 2 | SS | IRESSA | GEFITINIB | 1 | Oral | 10500 | MG | D | 206995 | 250 | MG | TABLET | QD | ||||
| 126550172 | 12655017 | 3 | C | AMITIZA | LUBIPROSTONE | 1 | 0 | ||||||||||||
| 126550172 | 12655017 | 4 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | ||||||||||||
| 126550172 | 12655017 | 5 | C | PROCHLORPERAZINE. | PROCHLORPERAZINE | 1 | 0 | ||||||||||||
| 126550172 | 12655017 | 6 | C | ZOLPIDEM TARTRATE. | ZOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
| 126550172 | 12655017 | 7 | C | MEGESTROL ACETATE. | MEGESTROL ACETATE | 1 | 0 | ||||||||||||
| 126550172 | 12655017 | 8 | C | DIVALPROEX SODIUM. | DIVALPROEX SODIUM | 1 | 0 | ||||||||||||
| 126550172 | 12655017 | 9 | C | LAZANDA | FENTANYL CITRATE | 1 | 0 | ||||||||||||
| 126550172 | 12655017 | 10 | C | OXYCODONE-ACETAMINOPHEN | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126550172 | 12655017 | 11 | C | FENTANYL. | FENTANYL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126550172 | 12655017 | 1 | Lung neoplasm malignant |
| 126550172 | 12655017 | 2 | Non-small cell lung cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126550172 | 12655017 | OT |
| 126550172 | 12655017 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126550172 | 12655017 | Death | |
| 126550172 | 12655017 | Malignant neoplasm progression | |
| 126550172 | 12655017 | Metastases to central nervous system | |
| 126550172 | 12655017 | Mood swings | |
| 126550172 | 12655017 | Rash | |
| 126550172 | 12655017 | Stomatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126550172 | 12655017 | 1 | 20160628 | 0 | ||
| 126550172 | 12655017 | 2 | 20160628 | 0 |